Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization

Cancer Genet Cytogenet. 2000 Jul 1;120(1):44-9. doi: 10.1016/s0165-4608(99)00252-6.


Neuroblastoma, the most common extracranial solid tumor of childhood, is associated with a number of genetic abnormalities that are prognostically significant. The most common abnormalities are associated with aggressive clinical behavior and include deletion of distal chromosome 1p, NMYC amplification, and unbalanced gain of the long arm of chromosome 17. There are also other recurrent, but less frequent abnormalities, the clinical significance of which is uncertain. These less common abnormalities include deletion 3p, 11q, and 14q. To gain further clinical insight into some of the less commonly observed abnormalities in neuroblastoma, we performed comparative genomic hybridization (CGH) analysis on 24 primary and metastatic neuroblastomas (6 stage 2, 5 stage 3, 11 stage 4, and 2 stage 4). Nineteen of these tumors were prechemotherapy. A total of 190 abnormalities were detected from these tumors. Four of the 24 tumors studied showed loss of 11q material, with 3 of these tumors also possessing distal chromosome 3p deletions. Our results provide confirmation that deletion of chromosome 3p is nonrandomly associated with deletion of chromosome 11q in neuroblastoma. However, analysis of our results, along with other results reported in the literature, indicate that there is no statistically significant association between 3p and 11q loss and more clinically aggressive tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Neoplasms / genetics
  • Biopsy
  • Chromosome Aberrations
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 11*
  • Chromosomes, Human, Pair 3*
  • Humans
  • Neoplasm Metastasis
  • Neuroblastoma / genetics*
  • Nucleic Acid Hybridization
  • Pelvic Neoplasms / genetics
  • Thoracic Neoplasms / genetics